INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

131 studies · page 5 of 6

2014 / Meta-analysis of prospective cohort studies

Greater Mediterranean diet adherence is linked to lower mortality and chronic disease risk.

In an updated meta-analysis encompassing 4,172,412 individuals, researchers evaluated how Mediterranean diet adherence related to clinical outcomes. A two-point increase in adherence score was linked to an 8% lower risk of all-cause mortality (RR 0.92, 95% CI 0.91 to 0.93). It was also linked to a 10% lower cardiovascular disease risk (RR 0.90, 95% CI 0.87 to 0.92) and a 4% lower risk of neoplastic disease (RR 0.96, 95% CI 0.95 to 0.97).

Shows an association, not proof of cause and effect.

NANO counterpoint →

Sofi F, Macchi C, Abbate R, et al. Public Health Nutr, 2014. PMID 24476641

2014 / Systematic review and meta-analysis of cohort studies and randomized controlled trials

Vitamin D3 supplementation reduced all-cause mortality, while circulating vitamin D was inversely linked to deaths.

In an analysis of 73 observational cohorts with 849,412 adults, lowest versus highest circulating 25-hydroxyvitamin D was associated with higher cardiovascular mortality (RR 1.35; 95% CI: 1.13-1.61) and all-cause mortality (RR 1.35; 95% CI: 1.22-1.49). Across 22 randomized trials with 30,716 participants, vitamin D3 supplementation reduced all-cause mortality (RR 0.89; 95% CI: 0.80-0.99), whereas vitamin D2 did not show a clear benefit (RR 1.04; 95% CI: 0.97-1.11).

Chowdhury R, Kunutsor S, Vitezova A, et al. BMJ, 2014. PMID 24690623

2014 / Systematic review of 16 studies (9 RCTs)

Oral melatonin significantly elevates post-intervention melatonin levels in older adults in a dose-dependent manner.

A systematic review of 16 articles evaluated the dose-response effect of oral exogenous melatonin (0.1 mg to 50 mg/kg) on melatonin levels in adults aged 55 years and older. Pre- and post-intervention measurements showed a significant, dose-dependent elevation of post-intervention melatonin levels. Maximum concentrations in serum and urine were elevated compared with placebo, showing higher elevations in older than in younger adults. While time to maximum concentration did not differ, higher doses maintained levels longer above a threshold than lower doses.

Vural EM, van Munster BC, de Rooij SE Drugs Aging, 2014. PMID 24802882

2014 / Meta-analysis of randomized controlled trials

Vitamin D supplementation produced a small positive effect on muscle strength.

A meta-analysis analyzed 30 randomized controlled trials including 5,615 individuals with a mean age of 61.1 years. Vitamin D supplementation had a small positive effect on overall muscle strength (SMD 0.17; P = .02), particularly in participants with baseline 25-hydroxyvitamin D below 30 nmol/L and those aged 65 or older. No significant improvements occurred in muscle mass (SMD 0.058; P = .52) or muscle power (SMD 0.057; P = .657).

Beaudart C, Buckinx F, Rabenda V, et al. J Clin Endocrinol Metab, 2014. PMID 25033068

2014 / Systematic review and meta-analysis of randomized controlled trials

Vitamin E supplementation at doses of 23 to 800 IU/day showed no effect on all-cause mortality in healthy adults.

A systematic review and meta-analysis of 18 RCTs evaluated the effect of oral vitamin E supplementation on all-cause mortality in 142,219 apparently healthy participants with at least 6 months of follow-up. Fixed effect and random effects analyses showed that vitamin E supplementation was not associated with all-cause mortality (RR 1.01, 95% CI 0.97-1.05, p = 0.65). Subgroup analyses by vitamin E type (natural or synthetic), dose or duration, study design, quality, or pre-specified mortality outcome also found no association.

Curtis AJ, Bullen M, Piccenna L, et al. Cardiovasc Drugs Ther, 2014. PMID 25398301

2013 / Meta-analysis

High serum urate levels were linked to a lower risk of Parkinson's disease, especially in men.

A meta-analysis of six studies with 33,185 participants evaluated the link between serum urate and Parkinson's disease (PD). High serum urate was associated with a 33% reduction in PD incidence overall (RR=0.67; 95% CI, 0.50-0.91), showing statistically significant protective effects in men (RR=0.60; 95% CI, 0.40-0.90) but not in women. A dose-response trend was observed (RR=0.77; 95% CI, 0.68-0.88), and high levels seemed to slow clinical decline in PD patients (RR=0.56; 95% CI, 0.43-0.72).

Shows an association, not proof of cause and effect.

Shen C, Guo Y, Luo W, et al. Can J Neurol Sci, 2013. PMID 23250131

2013 / Systematic review and dose-response meta-analyses

Higher homocysteine was linked to higher fracture risk, while higher vitamin B12 showed a borderline association with lower fracture risk in adults.

A systematic review and dose-response meta-analyses examined vitamin B12, folate, and homocysteine status in relation to fractures and BMD across 27 observational studies and one RCT. Meta-analysis of four prospective studies (n = 7,475) linked each 50 pmol/L increase in vitamin B12 to a borderline significant 4% decrease in fracture risk (RR = 0.96, 95% CI = 0.92 to 1.00). Meta-analysis of eight studies (n = 11,511) linked each μmol/L increase in homocysteine to a 4% increase in fracture risk (RR = 1.04, 95% CI = 1.02 to 1.07). Too few studies existed to draw conclusions for folate and fracture risk, and meta-analyses in female populations found no associations between vitamin B12, folate, or homocysteine levels and BMD.

Shows an association, not proof of cause and effect.

van Wijngaarden JP, Doets EL, Szczecińska A, et al. J Nutr Metab, 2013. PMID 23509616

2013 / Meta-analysis of double-blind, placebo-controlled RCTs

In elderly men, DHEA supplementation was linked to a small reduction in fat mass that depended on conversion to downstream metabolites.

A meta-analysis of 25 double-blind, placebo-controlled RCTs evaluated oral DHEA supplementation in 1,353 elderly men with a mean follow-up of 36 weeks. DHEA supplementation was associated with a reduction in fat mass (standardized mean difference -0.35 [-0.65 to -0.05]; P = .02), though this association disappeared after adjusting for increases in total testosterone and estradiol. No effects compared to placebo were observed for lipid and glycemic metabolism, bone health, sexual function, or quality of life.

Corona G, Rastrelli G, Giagulli VA, et al. J Clin Endocrinol Metab, 2013. PMID 23824417

2013 / Systematic review and meta-analysis of controlled trials

Walking did not significantly alter overall BMD in perimenopausal and postmenopausal women, but interventions over 6 months increased femoral neck BMD.

Ten randomized and nonrandomized controlled trials evaluated walking interventions on bone mineral density (BMD) in perimenopausal and postmenopausal women. Meta-analysis showed no significant effect on lumbar spine BMD (WMD 0.01 g/cm², 95% CI -0.00 to 0.02; P = 0.05), the radius (WMD -0.01 g/cm, 95% CI -0.06 to 0.04; P = 0.71), or the whole body (WMD 0.04 g/cm², 95% CI -0.00 to 0.08; P = 0.06). While femoral neck BMD showed no significant overall effect across all trials (WMD 0.01 g/cm², 95% CI -0.00 to 0.01; P = 0.07), positive effects were evident with interventions lasting more than 6 months (6 months to 1-2 years).

Ma D, Wu L, He Z Menopause, 2013. PMID 24149921

2012 / Systematic review

Dietary copper, saturated fat, and elevated brain iron linked to Alzheimer's pathology.

A systematic review evaluated 101 studies and reports on copper, iron, and Alzheimer's disease. Eleven interventional trials supplementing or depleting these minerals failed to demonstrate cognitive benefits in patients with Alzheimer's disease. Prospective observational evidence linked cognitive decline to diets simultaneously elevated in copper and saturated fatty acids. Brain iron was elevated in Alzheimer's cases, whereas copper was predominantly unchanged in brain tissue but elevated in serum.

Loef M, Walach H Br J Nutr, 2012. PMID 21767446

2012 / Systematic review and meta-analysis of cohort studies

Higher dietary lutein and zeaxanthin intake was linked to a lower risk of late and neovascular AMD, but not early AMD.

A systematic review and meta-analysis of six longitudinal cohort studies examined the relationship between dietary lutein and zeaxanthin intake and age-related macular degeneration (AMD) risk. Comparing the highest with the lowest intake categories, the pooled relative risk was 0.96 (95% CI 0.78, 1.17) for early AMD. Intake was significantly linked to a reduced risk of late AMD (RR 0.74; 95% CI 0.57, 0.97) and neovascular AMD (RR 0.68; 95% CI 0.51, 0.92).

Shows an association, not proof of cause and effect.

Ma L, Dou HL, Wu YQ, et al. Br J Nutr, 2012. PMID 21899805

2012 / Systematic review and meta-analysis of randomized controlled trials

Antioxidant supplements did not reduce mortality and in low-bias trials significantly increased mortality, particularly beta-carotene and vitamin E.

Researchers analyzed 78 randomized trials examining oral antioxidant supplements (beta-carotene, vitamin A, vitamin C, vitamin E, selenium) versus placebo or no intervention. Overall, antioxidant supplements had no significant effect on mortality under a random-effects model (RR 1.02, 95% CI 0.98 to 1.05), but significantly increased mortality in a fixed-effect model (RR 1.03, 95% CI 1.01 to 1.05). In 56 trials with low risk of bias, supplements significantly increased mortality (RR 1.04, 95% CI 1.01 to 1.07), driven by beta-carotene (RR 1.05, 95% CI 1.01 to 1.09) and vitamin E (RR 1.03, 95% CI 1.00 to 1.05). Vitamin A, vitamin C, and selenium did not significantly affect mortality, though higher vitamin A doses were linked to increased mortality in meta-regression (P = 0.002).

Bjelakovic G, Nikolova D, Gluud LL, et al. Cochrane Database Syst Rev, 2012. PMID 22419320

2012 / Meta-analysis

Alzheimer's disease was linked to higher copper levels in a meta-analysis.

Researchers updated a meta-analysis on copper levels in serum, plasma, and cerebrospinal fluid in Alzheimer's disease. The authors excluded four of five previous studies from their laboratory to limit bias and added two newer serum copper investigations. Across the analyzed studies, patients with Alzheimer's disease demonstrated higher copper concentrations than healthy controls.

Ventriglia M, Bucossi S, Panetta V, et al. J Alzheimers Dis, 2012. PMID 22475798

2012 / Systematic review

In older adults, overweight or mildly obese BMI ranges were linked to lowest mortality, though findings on the strongest predictor were inconsistent.

A systematic review of older adults evaluated 25 studies for comorbidity and 17 for mortality. Most evaluated studies relied on anthropometric measures such as BMI, waist circumference, and waist-hip ratio, with relatively few using direct measures like body fat/lean mass. Reported findings were inconsistent regarding the strongest predictor of morbidity and mortality. However, most studies suggested BMI alone was not the most appropriate predictor because it cannot detect age-related body fat redistribution, and studies using BMI found the lowest mortality at overweight (25 kg/m²≤BMI<30 kg/m²) or mildly obese (30 kg/m²≤BMI<35 kg/m²) ranges.

Shows an association, not proof of cause and effect.

Chang SH, Beason TS, Hunleth JM, et al. Maturitas, 2012. PMID 22595204

2012 / Systematic review and meta-analysis of randomized controlled trials

Omega-3 supplementation did not improve cognitive function in cognitively healthy older adults.

Three randomized controlled trials evaluated omega-3 fatty acid supplementation for 6 to 40 months in healthy adults aged 60 and older. In two trials with 3,221 participants, Mini-Mental State Examination scores did not differ between omega-3 and placebo groups (MD -0.07, 95% CI -0.25 to 0.10). Tests of word learning, digit span, and verbal fluency in 1,043 participants also showed no benefits, and incident dementia was not evaluated.

Sydenham E, Dangour AD, Lim WS Cochrane Database Syst Rev, 2012. PMID 22696350

2012 / Systematic review and meta-analysis of prospective cohorts

Combining at least four healthy lifestyle behaviors is associated with lower mortality risk.

A systematic review and meta-analysis examined prospective studies evaluating combined lifestyle behaviors including diet, physical activity, smoking, alcohol, and obesity. Across 15 studies with 531,804 individuals followed for an average of 13.24 years, adhering to at least four healthy lifestyle factors was linked to a 66% lower risk of all-cause mortality (95% CI 58% to 73%) compared to having the fewest healthy factors.

Shows an association, not proof of cause and effect.

Loef M, Walach H Prev Med, 2012. PMID 22735042

2012 / Systematic review of cohort studies

Vegetable but not fruit intake was linked to lower dementia risk.

A systematic review evaluated nine cohort studies with 44,004 participants on fruit and vegetable intake and cognitive decline or dementia. Out of six studies evaluating fruit and vegetables separately, five found that higher vegetable intake was associated with a decreased risk of dementia or cognitive decline. Conversely, evidence was lacking for an association between high fruit intake and reduced risk.

Shows an association, not proof of cause and effect.

Loef M, Walach H J Nutr Health Aging, 2012. PMID 22836704

2011 / Systematic review and meta-analysis of cohort studies

Non-vigorous physical activity was linked to lower all-cause mortality in adults.

A systematic review and meta-analysis examined 22 cohort studies totaling 977,925 adults to quantify non-vigorous physical activity and mortality. Compared with inactivity, 2.5 hours per week of moderate activity was associated with a 19% reduction in mortality risk (95% CI 15-24). Engaging in 7 hours per week of moderate activity was linked to a 24% reduction in risk (95% CI 19-29), with the greatest incremental benefit observed when moving from no activity to low levels.

Shows an association, not proof of cause and effect.

Woodcock J, Franco OH, Orsini N, et al. Int J Epidemiol, 2011. PMID 20630992

2011 / Meta-analysis of prospective cohort studies

Physical activity was linked to a lower risk of cognitive decline in nondemented individuals.

A systematic meta-analysis evaluated 15 prospective studies (12 cohorts) including 33,816 nondemented individuals followed for 1 to 12 years, during which 3,210 participants experienced cognitive decline. Using a random-effects model, high physical activity was significantly associated with a 38% lower risk of cognitive decline compared to low activity (HR 0.62, 95% CI 0.54-0.70; P < 0.00001). Low-to-moderate physical activity was also linked to a 35% lower risk of cognitive impairment (HR 0.65, 95% CI 0.57-0.75; P < 0.00001).

Shows an association, not proof of cause and effect.

Sofi F, Valecchi D, Bacci D, et al. J Intern Med, 2011. PMID 20831630

2011 / Systematic review and meta-analysis of randomized controlled trials

Vitamin D supplementation did not improve muscle strength in replete adults but increased hip strength in deficient adults.

A systematic review and meta-analysis of 17 randomized controlled trials evaluated the effect of vitamin D supplementation on muscle strength in 5,072 adults. In adults with baseline 25(OH)D levels > 25 nmol/L, supplementation showed no significant effect on grip strength (SMD -0.02, 95% CI -0.15 to 0.11) or proximal lower limb strength (SMD 0.1, 95% CI -0.01 to 0.22). However, pooled data from two studies in vitamin D-deficient participants (25(OH)D < 25 nmol/L) demonstrated a large effect on hip muscle strength (SMD 3.52, 95% CI 2.18 to 4.85).

Stockton KA, Mengersen K, Paratz JD, et al. Osteoporos Int, 2011. PMID 20924748

2011 / Systematic review

A systematic review indicates that DHEA supplementation may improve ovarian function, pregnancy chances, and ovarian reserve in women with diminished reserve.

Researchers conducted a systematic review searching PubMed, Cochrane, and Ovid Medline between 1995 and 2010 for studies on DHEA or androgens and ovarian reserve or function. Because only one prospectively randomized study had been published, publications were reviewed regardless of evidence level or quality assessment. Current best available evidence suggests that DHEA improves ovarian function, increases pregnancy chances, lowers miscarriage rates by reducing aneuploidy, and objectively improves ovarian reserve over time.

Gleicher N, Barad DH Reprod Biol Endocrinol, 2011. PMID 21586137

2011 / Systematic review and meta-analysis of randomized trials

Vitamin D3 supplementation significantly decreased mortality in adults, while vitamin D2, alfacalcidol, and calcitriol showed no significant effect.

A Cochrane systematic review examined 50 randomized trials encompassing 94,148 participants (mostly elderly women older than 70 years) given vitamin D for a median of two years. Overall, vitamin D decreased mortality (RR 0.97, 95% CI 0.94 to 1.00). When analyzed by form, only vitamin D3 significantly reduced mortality (RR 0.94, 95% CI 0.91 to 0.98; 32 trials, 74,789 participants), whereas vitamin D2, alfacalcidol, or calcitriol did not. However, vitamin D3 combined with calcium increased the risk of nephrolithiasis (RR 1.17, 95% CI 1.02 to 1.34), and alfacalcidol and calcitriol increased the risk of hypercalcemia (RR 3.18, 95% CI 1.17 to 8.68).

Bjelakovic G, Gluud LL, Nikolova D, et al. Cochrane Database Syst Rev, 2011. PMID 21735411

2011 / Systematic review and meta-analysis of RCTs

Vitamin D supplementation improves balance and lower extremity strength in older adults.

A meta-analysis of 13 randomized controlled trials evaluated vitamin D supplementation without exercise in adults aged 60 and older. Supplementation reduced postural sway (SMD -0.20, 95% CI -0.39 to -0.01) and shortened time on the Timed Up and Go Test (SMD -0.19, 95% CI -0.35 to -0.02). Lower extremity strength gain was also observed (SMD 0.05, 95% CI -0.11 to 0.20, P = .04), while trials using daily doses of 800 to 1,000 IU consistently improved balance and strength.

Muir SW, Montero-Odasso M J Am Geriatr Soc, 2011. PMID 22188076

2011 / Systematic review of randomized controlled trials

A review of 16 RCTs found that 7 reported beneficial effects of vitamin D supplements on muscle strength, body sway, or physical performance in older adults.

A systematic search identified 16 randomized controlled trials assessing the effects of vitamin D treatment on muscle function. All except one study included participants over 50 years old, and baseline 25-hydroxyvitamin D was below 50 nmol/l in 11 studies. Seven studies reported beneficial effects on lower leg muscle strength, body sway, and/or physical performance, while more studies showed a lack of effect. The studies were heterogeneous across most aspects, and few reported statistical power.

Rejnmark L Ther Adv Chronic Dis, 2011. PMID 23251739